REG - Clean Power Hydrogen - Memorandum of Understanding with Koch Modular

Clean Power HydrogenAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260407:nRSG3415Za&default-theme=true

RNS Number : 3415Z  Clean Power Hydrogen PLC  07 April 2026

 

7 April 2026

Clean Power Hydrogen plc

("CPH2" or the "Company")

 

Memorandum of Understanding with Koch Modular Process Systems LLC for
manufacture and licensing in North America.

 

CPH2 (AIM:CPH2), the developer of the market disrupting and IP-protected
Membrane-Free Electrolyser ("MFE") technology for the production of commercial
high purity hydrogen and above medical-grade purity oxygen, announces that it
has entered into a non-binding Memorandum of Understanding ("MoU") with Koch
Modular Process Systems LLC ("Koch Modular").

 

Based in Paramus, New Jersey, and Houston, Texas, Koch Modular specialises in
the design and manufacturing of modular mass transfer systems for the chemical
process industry and is a subsidiary of Koch Industries LLC, one of the
largest privately held corporations in the USA.

 

The MoU, which has an initial term of 24 months, provides a framework for the
parties to evaluate technical, commercial and operational feasibility,
including supply chain and localisation requirements. Pursuant to these
workstreams is the intention of Koch Modular and CPH2 to progress discussions
towards a legally binding agreement in relation to manufacturing and/or
licensing of up to 100MW of CPH2's proprietary modular hydrogen technology for
sales and marketing into Mexico, the USA and Canada.

 

Further updates in respect of the progress towards a legally binding agreement
between the parties will follow in due course.

 

Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "Our discussions
with Koch Modular cover joint supply chain, feasibility and technical
assessments; system concepts and manufacturing proposals; commercial
structures; and a manufacturing and/or licensing agreement for up to 100 MW of
membrane-free electrolysis capacity. With capabilities in process, product and
project delivery, we believe Koch Modular is a perfect partner to licence
CPH2's technology across North America. We look forward to updating the market
further on this in due course."

 

Commenting, Vice President of Koch Modular, Brian Loftus, said: "We are
pleased to begin discussions with CPH2. From our initial engagement, we
recognise the unique proposition of CPH2's patented MFE technology and look
forward to formalising our relationship as we look to leverage our expertise
in design and manufacture for the North American market"

ENDS

Enquiries:

 

 Clean Power Hydrogen                                          +44 1302 328075

 Jon Duffy, Chief Executive Officer

 James Hobson, Chief Financial Officer

 Cavendish Capital Markets Limited - NOMAD & Joint Broker

 Neil McDonald                                                 +44 131 220 9771

 Peter Lynch                                                   +44 131 220 9772

 Turner Pope Investments (TPI) Limited - Joint Broker

 Andy Thacker                                                  +44 203 657 0050

 Guy McDougall

 

Background on CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a
decade of dedicated research and product development experience that has
delivered global patents in breakthrough hydrogen and oxygen production
technology. The Group's strategic objective is to deliver the lowest lifetime
Levelised Cost of Hydrogen ("LCoH") in the market in relation to the
production of hydrogen for the growing decentralised markets, which include
wastewater treatment, curtailed wind power capture, data centre backup,
medical and life sciences, and heavy-duty mobility applications.. CPH2 is
listed on the AIM market and trades under the ticker AIM: CPH2.

 

For more information: https://www.cph2.com (https://www.cph2.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCDLLFBQZLZBBX



            Copyright 2019 Regulatory News Service, all rights reserved